Peanut Butter Firm’s GMP “Deviation” Offers Lessons For Manufacturers
This article was originally published in The Tan Sheet
Executive Summary
Shipping product once found to be contaminated, but later rated as safe in tests by a second source is not a good manufacturing practice, according to FDA
You may also be interested in...
Dry Labs Threaten Manufacturer GMP Compliance, Reputation
Recent media reports push to the forefront the threat posed by dry labs that falsely claim to test products for manufacturers. Manufacturers should qualify and regularly audit labs to reduce this risk, which places them on the hook for potential GMP violations, industry leaders say.
Dry Labs Threaten Manufacturer GMP Compliance, Reputation
Recent media reports push to the forefront the threat posed by dry labs that falsely claim to test products for manufacturers. Manufacturers should qualify and regularly audit labs to reduce this risk, which places them on the hook for potential GMP violations, industry leaders say.
Whey Recall Grows, But Plainview Approach May Prevent A Peanut Replay
The recall of whey protein ingredients rippling its way through the dietary supplement industry shows that companies must take a risk-based approach to product safety and cannot rely on good manufacturing practices alone to protect them